Amphetamine Extended-release Tablet, Orally Disintegrating
Product Images NDC 62542-005

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amphetamine Extended-release (NDC 62542-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Amphetamine Er Orally 1)

FDA Label Image

Figure 1 (Amphetamine Er Orally 2)

This text mentions the concentration of Dextroamphetamine and Levoamphetamine in ng/ml over time in a sustained-release formulation. It appears to be part of a scientific or medical study, providing data on the pharmacokinetics of these medications.*

FDA Label Image

3.1 mg (Amphetamine Er Orally 3)

FDA Label Image

6.3 mg (Amphetamine Er Orally 4)

FDA Label Image

9.4 mg (Amphetamine Er Orally 5)

FDA Label Image

12.5 mg (Amphetamine Er Orally 6)

FDA Label Image

15.7 mg (Amphetamine Er Orally 7)

FDA Label Image

18.8 mg (Amphetamine Er Orally 8)

This is a description of a pharmaceutical product packaging for Amphetamine Extended-Release Orally Disintegrating Tablets. The packaging includes information about the product, dosage, and instructions for use. The text also mentions "NO COATING" and provides contact information for the manufacturer or distributor.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.